TDB Call for Proposals — Advance Medical Technologies and Therapeutics is a loan from Technology Development Board (TDB), Department of Science & Technology for any Indian company incorporated under the Companies Act 1956 or 2013 that intends to commercialise indigenous medical technology or…. It provides Loan at 5% simple annual interest, or equity, from TDB (no fixed cap stated in the call). The current deadline is 23 November 2026.
Key facts
| Amount / benefit | Loan at 5% simple annual interest, or equity, from TDB (no fixed cap stated in the call) (Loan at 5% simple annual interest, or equity, from TDB (no fixed cap stated in the call)) |
|---|---|
| Provider | Technology Development Board (TDB), Department of Science & Technology |
| Where | Pan-India |
| Stage | Early Revenue, Growth, Prototype |
| Deadline | 23 November 2026 |
What is TDB Call for Proposals?
TDB Call for Proposals — Advance Medical Technologies and Therapeutics — Loan at 5% simple annual interest, or equity, from TDB (no fixed cap stated in the call) — Any Indian company incorporated under the Companies Act 1956 or 2013 that intends to commercialise indigenous medical technology or therapeutics (new product development, manufacturing, commercialisation or technology adaptation). It is run by Technology Development Board (TDB), Department of Science & Technology.
This is equity funding — the investor (often through a fund) takes a stake in your company in exchange for capital, rather than lending or granting money. You give up some ownership; you don’t repay it like a loan. The amount and form of support that actually apply to you depend on the programme’s rules and how your application is assessed — they are not fixed for every applicant.
Like most government programmes, it has its own eligibility conditions, documentation and application window, and these terms are revised from time to time. Because of that, it is worth confirming the current eligibility, amount and deadline on the official programme page before you invest time in applying.
Who is eligible for TDB Call for Proposals?
Any Indian company incorporated under the Companies Act 1956 or 2013 that intends to commercialise indigenous medical technology or therapeutics (new product development, manufacturing, commercialisation or technology adaptation). Not for: Entities that are not companies under the Companies Act (for example sole proprietors, partnerships, institutions)..
How much does TDB Call for Proposals give, and in what form?
Loan at 5% simple annual interest, or equity, from TDB (no fixed cap stated in the call), as loan at 5% simple annual interest, or equity, from TDB (no fixed cap stated in the call).
Frequently asked questions
What kind of support is this?
This is equity funding — the investor (often through a fund) takes a stake in your company in exchange for capital, rather than lending or granting money. You give up some ownership; you don’t repay it like a loan.
Who runs this programme?
TDB Call for Proposals — Advance Medical Technologies and Therapeutics is offered by Technology Development Board (TDB), Department of Science & Technology. Eligibility and approval rest with them; the criteria and amounts are set by the programme.
Is there a deadline to apply?
The programme lists a deadline of 2026-11-23. Government timelines can change, so confirm the current date on the official programme page before you apply.
How do I know if I’m eligible?
Read “Who can apply” above for the programme’s own criteria. If you’d like a quick read on your specific case, our free 2-minute eligibility check maps your stage, sector and revenue to what you can realistically claim.
Related programmes
Browse similar loan programmes. CapEasy handles this under Working-capital loan advisory.
Source and verification
No official page is linked for this programme yet. Verification date pending. Government programmes change — confirm current eligibility, amounts and deadlines on the official programme page before you apply. CapEasy is a private consultancy and is not affiliated with any government authority.